Salmonella AvrA Coordinates Suppression of Host Immune and Apoptotic Defenses via JNK Pathway Blockade

Cell Host & Microbe
Rheinallt M JonesAndrew S Neish

Abstract

Salmonellae are bacterial pathogens that have evolved sophisticated strategies to evade host immune defenses. These strategies include the secretion of effector proteins into mammalian cells so as to subvert innate immune and apoptotic signaling pathways, thereby allowing Salmonella to avoid elimination. Here, we show that the secreted Salmonella typhimurium effector protein AvrA possesses acetyltransferase activity toward specific mitogen-activated protein kinase kinases (MAPKKs) and potently inhibits c-Jun N-terminal kinase (JNK) and NF-kappaB signaling pathways in both transgenic Drosophila and murine models. Furthermore, we show that AvrA dampens the proapoptotic innate immune response to Salmonella at the mouse intestinal mucosa. This activity is consistent with the natural history of Salmonella in mammalian hosts, where the bacteria elicit transient inflammation but do not destroy epithelial cells. Our findings suggest that targeting JNK signaling to dampen apoptosis may be a conserved strategy for intracellular pathogens.

References

May 22, 1997·Nature·C FreibergX Perret
Sep 2, 1997·Proceedings of the National Academy of Sciences of the United States of America·W D Hardt, J E Galán
May 23, 1998·Science·N S DuesberyG F Vande Woude
Nov 5, 1999·Annual Review of Microbiology·Y Weinrauch, A Zychlinsky
Apr 11, 2000·Molecular and Cellular Biology·Y TakatsuN Ueno
Jun 26, 2001·Science·B J StaskawiczJ E Galan
Sep 20, 2001·Genes & Development·N Silverman, T Maniatis
Jun 18, 2002·The EMBO Journal·Tatsushi IgakiMasayuki Miura
Nov 7, 2003·Nature·Jules A Hoffmann
Jun 10, 2004·Microbiology and Molecular Biology Reviews : MMBR·Philippe P Roux, John Blenis
Oct 2, 2004·The Journal of Biological Chemistry·Jennifer E TroskyKim Orth
Sep 28, 2005·Nature Immunology·Shintaro SatoShizuo Akira
Feb 4, 2006·Proceedings of the National Academy of Sciences of the United States of America·Annabel GuichardEthan Bier
Sep 13, 2006·Infection and Immunity·Jinghua JiaShouguang Jin
Oct 31, 2006·The American Journal of Pathology·Matam Vijay-KumarAndrew S Neish
Jan 5, 2007·Annual Review of Immunology·Bruno Lemaitre, Jules Hoffmann
Feb 17, 2007·Current Opinion in Cell Biology·Claire R Weston, Roger J Davis
Feb 20, 2007·Immunity·Philippe J Sansonetti, James P Di Santo
Aug 11, 2007·The American Journal of Pathology·Zhongde YeJun Sun
Aug 19, 2007·Current Opinion in Microbiology·Jeffrey G EllisGregory J Lawrence

❮ Previous
Next ❯

Citations

Apr 2, 2013·Research in Microbiology·Tommaso TosiAndréa Dessen
May 1, 2009·Nature Cell Biology·Igor E Brodsky, Ruslan Medzhitov
Dec 17, 2011·Nature Chemical Biology·Hiroshi AshidaChihiro Sasakawa
Aug 21, 2013·Nature Reviews. Immunology·J Simon C Arthur, Steven C Ley
Sep 26, 2008·Proceedings of the National Academy of Sciences of the United States of America·Joel L FrandsenStuart J Newfeld
Jun 17, 2009·Current Opinion in Gastroenterology·Martina E Spehlmann, Lars Eckmann
Dec 2, 2010·Microbiology and Molecular Biology Reviews : MMBR·Trudy Torto-AlaliboBrett M Tyler
Sep 10, 2011·American Journal of Physiology. Gastrointestinal and Liver Physiology·Xingyin LiuJun Sun
Sep 18, 2012·American Journal of Physiology. Gastrointestinal and Liver Physiology·Rong LuJun Sun
Mar 13, 2010·American Journal of Physiology. Gastrointestinal and Liver Physiology·Shaoping WuJun Sun
Jan 12, 2013·PloS One·Francisco S MesquitaNathalie Rolhion
Aug 8, 2014·PLoS Pathogens·Adam J Caulfield, Wyndham W Lathem
Oct 31, 2013·Proceedings of the National Academy of Sciences of the United States of America·Jennifer D LewisDarrell Desveaux
Jan 21, 2014·Cytokine & Growth Factor Reviews·Cristina GioghaElizabeth L Hartland
Nov 30, 2011·The Journal of Cell Biology·Anne Marie KrachlerKim Orth
Nov 30, 2011·The Journal of Cell Biology·Hiroshi AshidaChihiro Sasakawa
Jan 23, 2016·Molecular Pharmaceutics·Lina Herrera EstradaJulie A Champion
Jan 31, 2012·Journal of Proteomics·Melania Collado-RomeroJuan J Garrido
Sep 17, 2011·Trends in Biochemical Sciences·Jixin Cui, Feng Shao
Oct 1, 2011·Trends in Microbiology·Andrew S Neish, Michael Naumann
Jul 6, 2011·Current Opinion in Immunology·Patrick Kaiser, Wolf-Dietrich Hardt
Nov 16, 2010·Trends in Biochemical Sciences·Go-Woon Kim, Xiang-Jiao Yang
Mar 5, 2016·Journal of Experimental Botany·Ying-Ying GeChristian Staehelin
Dec 2, 2008·International Journal of Medical Microbiology : IJMM·Tobias KerrinnesSima Yaron
Nov 26, 2008·Gastroenterology·Andrew S Neish
Dec 10, 2015·Frontiers in Immunology·Victoria A McGuire, J Simon C Arthur
Jan 8, 2015·Protein Science : a Publication of the Protein Society·Andrey M GrishinMiroslaw Cygler
Sep 25, 2009·Cellular Microbiology·J Antonio Ibarra, Olivia Steele-Mortimer
Jan 4, 2012·Proteomics. Clinical Applications·Sylvia SchlekerJudith Klein-Seetharaman
Oct 28, 2010·Traffic·Olivia Steele-Mortimer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis